Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 5

Global and United States Intranasal Drug Delivery System Market Report & Forecast 2022-2028

Global and United States Intranasal Drug Delivery System Market Report & Forecast 2022-2028

Industry: Medical Devices & Consumables

Published: 2022-04-21

Pages: 103 Pages

Report ld: 351508

  • Description 选中
  • Table of Contents 选中
  • Table of Figures 选中
  • PDF PDF Download 选中
  • Description 选中
  • Table of Contents 选中
  • Table of Figures 选中
  • PDF PDF Download 选中
Market Analysis and Insights: Global and United States Intranasal Drug Delivery System Market
This report focuses on global and United States Intranasal Drug Delivery System market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Intranasal Drug Delivery System market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Nasal Drops accounting for % of the Intranasal Drug Delivery System global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospital was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Intranasal Drug Delivery System market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period  2022-2028.

Global Intranasal Drug Delivery System Scope and Market Size
Intranasal Drug Delivery System market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Intranasal Drug Delivery System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Intranasal Drug Delivery System market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Nasal Drops
    Nasal Sprays
    Nasal Gels
    Nasal Suspensions and Emulsion
    Nasal Powders

Segment by Application
    Hospital
    Clinic
    Home Care
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Aptar Pharma
    Nemera
    Teleflex
    Mystic Pharmaceuticals
    Zeteo Medical
    Johnson & Johnson
    GlaxoSmithKline Plc
    Aegis Therapeutics LLC
    H&T Presspart Manufacturing Ltd.
    AstraZeneca Plc
    Becton
    BD
    Novartis AG
    Vectura Group Plc
 1 Study Coverage
1.1 Intranasal Drug Delivery System Product Introduction
1.2 Global Intranasal Drug Delivery System Outlook 2017 VS 2022 VS 2028
1.2.1 Global Intranasal Drug Delivery System Sales in US$ Million for the Year 2017-2028
1.2.2 Global Intranasal Drug Delivery System Sales in Volume for the Year 2017-2028
1.3 United States Intranasal Drug Delivery System Outlook 2017 VS 2022 VS 2028
1.3.1 United States Intranasal Drug Delivery System Sales in US$ Million for the Year 2017-2028
1.3.2 United States Intranasal Drug Delivery System Sales in Volume for the Year 2017-2028
1.4 Intranasal Drug Delivery System Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Intranasal Drug Delivery System in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Intranasal Drug Delivery System Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Intranasal Drug Delivery System Market Dynamics
1.5.1 Intranasal Drug Delivery System Industry Trends
1.5.2 Intranasal Drug Delivery System Market Drivers
1.5.3 Intranasal Drug Delivery System Market Challenges
1.5.4 Intranasal Drug Delivery System Market Restraints
1.6 Study Objectives
1.7 Years Considered

 2 Market by Type
2.1 Intranasal Drug Delivery System Market Segment by Type
2.1.1 Nasal Drops
2.1.2 Nasal Sprays
2.1.3 Nasal Gels
2.1.4 Nasal Suspensions and Emulsion
2.1.5 Nasal Powders
2.2 Global Intranasal Drug Delivery System Market Size by Type
2.2.1 Global Intranasal Drug Delivery System Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Intranasal Drug Delivery System Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Intranasal Drug Delivery System Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Intranasal Drug Delivery System Market Size by Type
2.3.1 United States Intranasal Drug Delivery System Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Intranasal Drug Delivery System Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Intranasal Drug Delivery System Average Selling Price (ASP) by Type (2017, 2022 & 2028)

 3 Market by Application
3.1 Intranasal Drug Delivery System Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Home Care
3.1.4 Others
3.2 Global Intranasal Drug Delivery System Market Size by Application
3.2.1 Global Intranasal Drug Delivery System Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Intranasal Drug Delivery System Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Intranasal Drug Delivery System Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Intranasal Drug Delivery System Market Size by Application
3.3.1 United States Intranasal Drug Delivery System Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Intranasal Drug Delivery System Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Intranasal Drug Delivery System Average Selling Price (ASP) by Application (2017, 2022 & 2028)

 4 Global Intranasal Drug Delivery System Competitor Landscape by Company
4.1 Global Intranasal Drug Delivery System Market Size by Company
4.1.1 Top Global Intranasal Drug Delivery System Manufacturers Ranked by Revenue (2021)
4.1.2 Global Intranasal Drug Delivery System Revenue by Manufacturer (2017-2022)
4.1.3 Global Intranasal Drug Delivery System Sales by Manufacturer (2017-2022)
4.1.4 Global Intranasal Drug Delivery System Price by Manufacturer (2017-2022)
4.2 Global Intranasal Drug Delivery System Concentration Ratio (CR)
4.2.1 Intranasal Drug Delivery System Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Intranasal Drug Delivery System in 2021
4.2.3 Global Intranasal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Intranasal Drug Delivery System Manufacturing Base Distribution, Product Type
4.3.1 Global Intranasal Drug Delivery System Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Intranasal Drug Delivery System Product Type
4.3.3 Date of International Manufacturers Enter into Intranasal Drug Delivery System Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Intranasal Drug Delivery System Market Size by Company
4.5.1 Top Intranasal Drug Delivery System Players in United States, Ranked by Revenue (2021)
4.5.2 United States Intranasal Drug Delivery System Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Intranasal Drug Delivery System Sales by Players (2020, 2021 & 2022)

 5 Global Intranasal Drug Delivery System Market Size by Region
5.1 Global Intranasal Drug Delivery System Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Intranasal Drug Delivery System Market Size in Volume by Region (2017-2028)
5.2.1 Global Intranasal Drug Delivery System Sales in Volume by Region: 2017-2022
5.2.2 Global Intranasal Drug Delivery System Sales in Volume Forecast by Region (2023-2028)
5.3 Global Intranasal Drug Delivery System Market Size in Value by Region (2017-2028)
5.3.1 Global Intranasal Drug Delivery System Sales in Value by Region: 2017-2022
5.3.2 Global Intranasal Drug Delivery System Sales in Value by Region: 2023-2028

 6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Intranasal Drug Delivery System Market Size YoY Growth 2017-2028
6.1.2 North America Intranasal Drug Delivery System Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Intranasal Drug Delivery System Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Intranasal Drug Delivery System Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Intranasal Drug Delivery System Market Size YoY Growth 2017-2028
6.3.2 Europe Intranasal Drug Delivery System Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Intranasal Drug Delivery System Market Size YoY Growth 2017-2028
6.4.2 Latin America Intranasal Drug Delivery System Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Intranasal Drug Delivery System Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Intranasal Drug Delivery System Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE

 7 Company Profiles
7.1 Aptar Pharma
7.1.1 Aptar Pharma Corporation Information
7.1.2 Aptar Pharma Description and Business Overview
7.1.3 Aptar Pharma Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Aptar Pharma Intranasal Drug Delivery System Products Offered
7.1.5 Aptar Pharma Recent Development
7.2 Nemera
7.2.1 Nemera Corporation Information
7.2.2 Nemera Description and Business Overview
7.2.3 Nemera Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Nemera Intranasal Drug Delivery System Products Offered
7.2.5 Nemera Recent Development
7.3 Teleflex
7.3.1 Teleflex Corporation Information
7.3.2 Teleflex Description and Business Overview
7.3.3 Teleflex Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Teleflex Intranasal Drug Delivery System Products Offered
7.3.5 Teleflex Recent Development
7.4 Mystic Pharmaceuticals
7.4.1 Mystic Pharmaceuticals Corporation Information
7.4.2 Mystic Pharmaceuticals Description and Business Overview
7.4.3 Mystic Pharmaceuticals Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Mystic Pharmaceuticals Intranasal Drug Delivery System Products Offered
7.4.5 Mystic Pharmaceuticals Recent Development
7.5 Zeteo Medical
7.5.1 Zeteo Medical Corporation Information
7.5.2 Zeteo Medical Description and Business Overview
7.5.3 Zeteo Medical Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Zeteo Medical Intranasal Drug Delivery System Products Offered
7.5.5 Zeteo Medical Recent Development
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Corporation Information
7.6.2 Johnson & Johnson Description and Business Overview
7.6.3 Johnson & Johnson Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Johnson & Johnson Intranasal Drug Delivery System Products Offered
7.6.5 Johnson & Johnson Recent Development
7.7 GlaxoSmithKline Plc
7.7.1 GlaxoSmithKline Plc Corporation Information
7.7.2 GlaxoSmithKline Plc Description and Business Overview
7.7.3 GlaxoSmithKline Plc Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.7.4 GlaxoSmithKline Plc Intranasal Drug Delivery System Products Offered
7.7.5 GlaxoSmithKline Plc Recent Development
7.8 Aegis Therapeutics LLC
7.8.1 Aegis Therapeutics LLC Corporation Information
7.8.2 Aegis Therapeutics LLC Description and Business Overview
7.8.3 Aegis Therapeutics LLC Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Aegis Therapeutics LLC Intranasal Drug Delivery System Products Offered
7.8.5 Aegis Therapeutics LLC Recent Development
7.9 H&T Presspart Manufacturing Ltd.
7.9.1 H&T Presspart Manufacturing Ltd. Corporation Information
7.9.2 H&T Presspart Manufacturing Ltd. Description and Business Overview
7.9.3 H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.9.4 H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Products Offered
7.9.5 H&T Presspart Manufacturing Ltd. Recent Development
7.10 AstraZeneca Plc
7.10.1 AstraZeneca Plc Corporation Information
7.10.2 AstraZeneca Plc Description and Business Overview
7.10.3 AstraZeneca Plc Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.10.4 AstraZeneca Plc Intranasal Drug Delivery System Products Offered
7.10.5 AstraZeneca Plc Recent Development
7.11 Becton
7.11.1 Becton Corporation Information
7.11.2 Becton Description and Business Overview
7.11.3 Becton Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Becton Intranasal Drug Delivery System Products Offered
7.11.5 Becton Recent Development
7.12 BD
7.12.1 BD Corporation Information
7.12.2 BD Description and Business Overview
7.12.3 BD Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.12.4 BD Products Offered
7.12.5 BD Recent Development
7.13 Novartis AG
7.13.1 Novartis AG Corporation Information
7.13.2 Novartis AG Description and Business Overview
7.13.3 Novartis AG Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Novartis AG Products Offered
7.13.5 Novartis AG Recent Development
7.14 Vectura Group Plc
7.14.1 Vectura Group Plc Corporation Information
7.14.2 Vectura Group Plc Description and Business Overview
7.14.3 Vectura Group Plc Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Vectura Group Plc Products Offered
7.14.5 Vectura Group Plc Recent Development

 8 Industry Chain and Sales Channels Analysis
8.1 Intranasal Drug Delivery System Industry Chain Analysis
8.2 Intranasal Drug Delivery System Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Intranasal Drug Delivery System Distributors
8.3 Intranasal Drug Delivery System Production Mode & Process
8.4 Intranasal Drug Delivery System Sales and Marketing
8.4.1 Intranasal Drug Delivery System Sales Channels
8.4.2 Intranasal Drug Delivery System Distributors
8.5 Intranasal Drug Delivery System Customers

 9 Research Findings and Conclusion

 10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Intranasal Drug Delivery System CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Intranasal Drug Delivery System Market Trends
    Table 3. Intranasal Drug Delivery System Market Drivers
    Table 4. Intranasal Drug Delivery System Market Challenges
    Table 5. Intranasal Drug Delivery System Market Restraints
    Table 6. Global Intranasal Drug Delivery System Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Intranasal Drug Delivery System Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Intranasal Drug Delivery System Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Intranasal Drug Delivery System Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Intranasal Drug Delivery System Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Intranasal Drug Delivery System Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Intranasal Drug Delivery System Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Intranasal Drug Delivery System Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Intranasal Drug Delivery System Sales Share by Manufacturer, 2017-2022
    Table 15. Global Intranasal Drug Delivery System Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Intranasal Drug Delivery System Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Intranasal Drug Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Drug Delivery System as of 2021)
    Table 18. Top Players of Intranasal Drug Delivery System in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Intranasal Drug Delivery System Product Type
    Table 20. Date of International Manufacturers Enter into Intranasal Drug Delivery System Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Intranasal Drug Delivery System Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Intranasal Drug Delivery System Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Intranasal Drug Delivery System Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Intranasal Drug Delivery System Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Intranasal Drug Delivery System Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Intranasal Drug Delivery System Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Intranasal Drug Delivery System Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Intranasal Drug Delivery System Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Intranasal Drug Delivery System Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Intranasal Drug Delivery System Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Intranasal Drug Delivery System Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Intranasal Drug Delivery System Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Intranasal Drug Delivery System Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Intranasal Drug Delivery System Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Intranasal Drug Delivery System Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Intranasal Drug Delivery System Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Intranasal Drug Delivery System Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Intranasal Drug Delivery System Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Intranasal Drug Delivery System Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Intranasal Drug Delivery System Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Aptar Pharma Corporation Information
    Table 43. Aptar Pharma Description and Business Overview
    Table 44. Aptar Pharma Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. Aptar Pharma Intranasal Drug Delivery System Product
    Table 46. Aptar Pharma Recent Development
    Table 47. Nemera Corporation Information
    Table 48. Nemera Description and Business Overview
    Table 49. Nemera Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. Nemera Product
    Table 51. Nemera Recent Development
    Table 52. Teleflex Corporation Information
    Table 53. Teleflex Description and Business Overview
    Table 54. Teleflex Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. Teleflex Product
    Table 56. Teleflex Recent Development
    Table 57. Mystic Pharmaceuticals Corporation Information
    Table 58. Mystic Pharmaceuticals Description and Business Overview
    Table 59. Mystic Pharmaceuticals Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Mystic Pharmaceuticals Product
    Table 61. Mystic Pharmaceuticals Recent Development
    Table 62. Zeteo Medical Corporation Information
    Table 63. Zeteo Medical Description and Business Overview
    Table 64. Zeteo Medical Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. Zeteo Medical Product
    Table 66. Zeteo Medical Recent Development
    Table 67. Johnson & Johnson Corporation Information
    Table 68. Johnson & Johnson Description and Business Overview
    Table 69. Johnson & Johnson Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. Johnson & Johnson Product
    Table 71. Johnson & Johnson Recent Development
    Table 72. GlaxoSmithKline Plc Corporation Information
    Table 73. GlaxoSmithKline Plc Description and Business Overview
    Table 74. GlaxoSmithKline Plc Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. GlaxoSmithKline Plc Product
    Table 76. GlaxoSmithKline Plc Recent Development
    Table 77. Aegis Therapeutics LLC Corporation Information
    Table 78. Aegis Therapeutics LLC Description and Business Overview
    Table 79. Aegis Therapeutics LLC Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. Aegis Therapeutics LLC Product
    Table 81. Aegis Therapeutics LLC Recent Development
    Table 82. H&T Presspart Manufacturing Ltd. Corporation Information
    Table 83. H&T Presspart Manufacturing Ltd. Description and Business Overview
    Table 84. H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 85. H&T Presspart Manufacturing Ltd. Product
    Table 86. H&T Presspart Manufacturing Ltd. Recent Development
    Table 87. AstraZeneca Plc Corporation Information
    Table 88. AstraZeneca Plc Description and Business Overview
    Table 89. AstraZeneca Plc Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 90. AstraZeneca Plc Product
    Table 91. AstraZeneca Plc Recent Development
    Table 92. Becton Corporation Information
    Table 93. Becton Description and Business Overview
    Table 94. Becton Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 95. Becton Product
    Table 96. Becton Recent Development
    Table 97. BD Corporation Information
    Table 98. BD Description and Business Overview
    Table 99. BD Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 100. BD Product
    Table 101. BD Recent Development
    Table 102. Novartis AG Corporation Information
    Table 103. Novartis AG Description and Business Overview
    Table 104. Novartis AG Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 105. Novartis AG Product
    Table 106. Novartis AG Recent Development
    Table 107. Vectura Group Plc Corporation Information
    Table 108. Vectura Group Plc Description and Business Overview
    Table 109. Vectura Group Plc Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 110. Vectura Group Plc Product
    Table 111. Vectura Group Plc Recent Development
    Table 112. Key Raw Materials Lists
    Table 113. Raw Materials Key Suppliers Lists
    Table 114. Intranasal Drug Delivery System Customers List
    Table 115. Intranasal Drug Delivery System Distributors List
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Intranasal Drug Delivery System Product Picture
    Figure 2. Global Intranasal Drug Delivery System Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Intranasal Drug Delivery System Market Size 2017-2028 (US$ Million)
    Figure 4. Global Intranasal Drug Delivery System Sales 2017-2028 (K Units)
    Figure 5. United States Intranasal Drug Delivery System Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Intranasal Drug Delivery System Market Size 2017-2028 (US$ Million)
    Figure 7. United States Intranasal Drug Delivery System Sales 2017-2028 (K Units)
    Figure 8. United States Intranasal Drug Delivery System Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Intranasal Drug Delivery System Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Intranasal Drug Delivery System Report Years Considered
    Figure 11. Product Picture of Nasal Drops
    Figure 12. Product Picture of Nasal Sprays
    Figure 13. Product Picture of Nasal Gels
    Figure 14. Product Picture of Nasal Suspensions and Emulsion
    Figure 15. Product Picture of Nasal Powders
    Figure 16. Global Intranasal Drug Delivery System Market Share by Type in 2022 & 2028
    Figure 17. Global Intranasal Drug Delivery System Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 18. Global Intranasal Drug Delivery System Sales Market Share in Value by Type (2017-2028)
    Figure 19. Global Intranasal Drug Delivery System Sales by Type (2017-2028) & (K Units)
    Figure 20. Global Intranasal Drug Delivery System Sales Market Share in Volume by Type (2017-2028)
    Figure 21. Global Intranasal Drug Delivery System Price by Type (2017-2028) & (US$/Unit)
    Figure 22. United States Intranasal Drug Delivery System Market Share by Type in 2022 & 2028
    Figure 23. United States Intranasal Drug Delivery System Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 24. United States Intranasal Drug Delivery System Sales Market Share in Value by Type (2017-2028)
    Figure 25. United States Intranasal Drug Delivery System Sales by Type (2017-2028) & (K Units)
    Figure 26. United States Intranasal Drug Delivery System Sales Market Share in Volume by Type (2017-2028)
    Figure 27. United States Intranasal Drug Delivery System Price by Type (2017-2028) & (US$/Unit)
    Figure 28. Product Picture of Hospital
    Figure 29. Product Picture of Clinic
    Figure 30. Product Picture of Home Care
    Figure 31. Product Picture of Others
    Figure 32. Global Intranasal Drug Delivery System Market Share by Application in 2022 & 2028
    Figure 33. Global Intranasal Drug Delivery System Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 34. Global Intranasal Drug Delivery System Sales Market Share in Value by Application (2017-2028)
    Figure 35. Global Intranasal Drug Delivery System Sales by Application (2017-2028) & (K Units)
    Figure 36. Global Intranasal Drug Delivery System Sales Market Share in Volume by Application (2017-2028)
    Figure 37. Global Intranasal Drug Delivery System Price by Application (2017-2028) & (US$/Unit)
    Figure 38. United States Intranasal Drug Delivery System Market Share by Application in 2022 & 2028
    Figure 39. United States Intranasal Drug Delivery System Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 40. United States Intranasal Drug Delivery System Sales Market Share in Value by Application (2017-2028)
    Figure 41. United States Intranasal Drug Delivery System Sales by Application (2017-2028) & (K Units)
    Figure 42. United States Intranasal Drug Delivery System Sales Market Share in Volume by Application (2017-2028)
    Figure 43. United States Intranasal Drug Delivery System Price by Application (2017-2028) & (US$/Unit)
    Figure 44. North America Intranasal Drug Delivery System Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 45. North America Intranasal Drug Delivery System Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. United States Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Canada Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Europe Intranasal Drug Delivery System Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 49. Europe Intranasal Drug Delivery System Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 50. Germany Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. France Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.K. Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Italy Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Russia Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Asia-Pacific Intranasal Drug Delivery System Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 56. Asia-Pacific Intranasal Drug Delivery System Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 57. China Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Japan Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. South Korea Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. India Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Australia Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. China Taiwan Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Indonesia Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Thailand Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Malaysia Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Intranasal Drug Delivery System Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 67. Latin America Intranasal Drug Delivery System Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Middle East & Africa Intranasal Drug Delivery System Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 72. Middle East & Africa Intranasal Drug Delivery System Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 73. Turkey Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Saudi Arabia Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. UAE Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Intranasal Drug Delivery System Value Chain
    Figure 77. Intranasal Drug Delivery System Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
Market Analysis and Insights: Global and United States Intranasal Drug Delivery System Market
This report focuses on global and United States Intranasal Drug Delivery System market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Intranasal Drug Delivery System market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Nasal Drops accounting for % of the Intranasal Drug Delivery System global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospital was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Intranasal Drug Delivery System market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period  2022-2028.

Global Intranasal Drug Delivery System Scope and Market Size
Intranasal Drug Delivery System market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Intranasal Drug Delivery System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Intranasal Drug Delivery System market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Nasal Drops
    Nasal Sprays
    Nasal Gels
    Nasal Suspensions and Emulsion
    Nasal Powders

Segment by Application
    Hospital
    Clinic
    Home Care
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Aptar Pharma
    Nemera
    Teleflex
    Mystic Pharmaceuticals
    Zeteo Medical
    Johnson & Johnson
    GlaxoSmithKline Plc
    Aegis Therapeutics LLC
    H&T Presspart Manufacturing Ltd.
    AstraZeneca Plc
    Becton
    BD
    Novartis AG
    Vectura Group Plc
    
Global and United States Intranasal Drug Delivery System Market Report & Forecast 2022-2028

Industry: Medical Devices & Consumables

Published: 2022-04-21

Pages: 103 Pages

Report ld: 351508

CHOOSE LICENSE TYPE
提示

USD 4350.00

提示

USD 6525.00

提示

USD 8700.00

/uploads/payment/payIcon/masterCard-01.svg/uploads/payment/payIcon/american-express-01.svg/uploads/payment/payIcon/visa-01.svg/uploads/payment/payIcon/diners-club-01.svg/uploads/payment/payIcon/discover-4-01.svg/uploads/payment/payIcon/jcb-01.svg
加入购物车

Add to Cart

立即购买

Buy Now

A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.

In-depth research on key industry players and analysis of production and sales operations.

Objective forecasts of future trends in the industry.

WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 17 years of vast experience

    More than 17 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.

In-depth research on key industry players and analysis of production and sales operations.

Objective forecasts of future trends in the industry.

WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 17 years of vast experience

    More than 17 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE

加入购物车

Add to Cart

立即购买

Buy Now